Streetbeat News

Analyst Ratings

NTLA

Morgan Stanley analyst Terence Flynn has maintained an Overweight rating on Intellia Therapeutics (NASDAQ:NTLA) but reduced the price target from $90 to $85.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 2:05 pm

AMD

BRCC

CTRA

HHH

PANW

SOFI

TDOC

UBER

Jim Cramer discussed several companies on CNBC's 'Mad Money Lightning Round.' He sees Advanced Micro Devices (AMD) as a 'good hold' and expects Palo Alto Networks (PANW) to report a 'very good quarter.' He advised against buying Teladoc Health (TDOC) due to a crowded market impacting margins. Cramer doesn't find BRC Inc. (BRCC) inexpensive enough and is not interested in Howard Hughes Holdings (HHH) due to its 'break up story.' He recommends buying Uber Technologies (UBER) and prefers Coterra Energy (CTRA) over EQT Corporation (EQT) for its better assets and lower price. Cramer also finds SoFi Technologies (SOFI) 'incredibly inexpensive' after a great quarter.

Portfolio Pulse from Lisa Levin

November 13, 2023 | 2:05 pm

IBM

Wedbush analyst Moshe Katri has reiterated a Neutral rating on IBM (NYSE:IBM) and maintained a price target of $140.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 2:04 pm

KROS

Wedbush analyst Andreas Argyrides has reiterated an Outperform rating on Keros Therapeutics (NASDAQ:KROS) and maintained a price target of $86.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 2:02 pm

SPRY

Wedbush analyst Andreas Argyrides has maintained an Outperform rating on ARS Pharmaceuticals (NASDAQ:SPRY) and increased the price target from $5 to $13.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 2:00 pm

HPQ

Over the past 3 months, 10 Wall Street analysts have provided ratings for HP Inc. (NYSE:HPQ), with an average 12-month price target of $30.7, a high of $39.00, and a low of $23.00. The current average price target represents a 0.97% decrease from the previous average of $31.00. The ratings include 2 bullish, 1 somewhat bullish, 5 indifferent, and 2 somewhat bearish opinions.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 2:00 pm

CL

Over the past 3 months, 9 Wall Street analysts have published their opinions on Colgate-Palmolive (NYSE:CL), with 4 bullish, 2 somewhat bullish, and 3 indifferent ratings. The average 12-month price target for CL is $81.22, with a high of $87.00 and a low of $73.00, representing a 4.6% decrease from the previous target of $85.14. Analyst ratings are important as they provide investors with insights into stock performance based on research and financial analysis.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 2:00 pm

KYMR

Kymera Therapeutics (NASDAQ:KYMR) has received mixed analyst ratings in the last quarter, with 1 bullish, 1 somewhat bullish, and 2 indifferent ratings. The average 12-month price target among 4 analysts is $32.25, with a high of $38.00 and a low of $24.00. This target suggests a significant 41.1% decrease from the previous target of $54.75. Analysts rate stocks based on future earnings potential and company updates.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 2:00 pm

ABM

ABM Industries (NYSE:ABM) has received 5 analyst ratings in the last quarter, with an average price target of $43.2, representing an implied upside from the current price of $39.99. The ratings are predominantly indifferent, with 4 out of 5 analysts giving neutral ratings and only 1 somewhat bullish. This average price target is a 20.73% decrease from the previous target of $54.50. Analysts base their ratings on financial predictions and company performance.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 2:00 pm

COCO

Vita Coco (NASDAQ:COCO) has received 4 analyst ratings in the last quarter, with an average 12-month price target of $31.5, a high of $35.00, and a low of $29.00. The current average price target has decreased by 1.56% from the previous average of $32.00. The ratings include 1 bullish, 1 somewhat bullish, and 2 indifferent, indicating a mixed but slightly positive outlook from analysts.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 2:00 pm